Dr. Schafenacker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1201 W La Veta Ave
Orange, CA 92868Phone+1 714-509-8826Fax+1 714-501-4169
Education & Training
University of California (Irvine)/Children's Hospital of Orange CountyFellowship, Pediatric Hospital Medicine, 2021 - 2023- University of California (Irvine)/Children's Hospital of Orange CountyChief Residency, Pediatrics, 2019 - 2020
- University of California (Irvine)/Children's Hospital of Orange CountyResidency, Pediatrics, 2016 - 2019
University of California, Irvine, School of MedicineClass of 2016
University of California at Los AngelesBS, Molecular, Cell, and Developmental Biology, Cum Laude, 2008 - 2012
Certifications & Licensure
CA State Medical License 2017 - 2025- American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- 1 citationsBalancing Life and Medical School.Victor Cisneros, Iliya Goldberg, Amanda Schafenacker, Robert G. Bota
Mental Illness. 2015-02-24 - 47 citationsEstrogen and progesterone together expand murine endometrial epithelial progenitor cells.Deanna M. Janzen, Donghui Cheng, Amanda M. Schafenacker, Daniel Y. Paik, Andrew S. Goldstein
Stem Cells. 2013-04-01 - 110 citationsStem‐Like Epithelial Cells Are Concentrated in the Distal End of the Fallopian Tube: A Site for Injury and Serous Cancer InitiationDaniel Y. Paik, Deanna M. Janzen, Amanda M. Schafenacker, Victor S. Velasco, May S. Shung
Stem Cells. 2012-11-01
Journal Articles
- Hematuria in a 7-year-old Internationally Adopted MaleAmanda Schafenacker, Jasjit Singh, The Pediatric Infectious Disease Journal, 10/2020
Abstracts/Posters
- No Device, But Still a Problem: A Five Year Review of Healthcare Associated Bloodstream and Urinary Tract Infections in a Children’s HospitalAmanda Schafenacker; Wendi Gornick; Beth Huff; Jasjit Singh, ID Week, Washington, DC, 10/22/2022
- Development of selective therapy of childhood ALL and Ewing's sarcoma using targeted-hybrid polymerized liposomal nanoparticles (HPLN)Kang K, Shahbazian V, Schafenacker A, Nagy J, Triche T., American Association of Cancer Research, San Diego, 4/2014
Professional Memberships
- Phi Beta KappaMember
- American Medical AssociationMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
